SMS Pharmaceuticals Monthly Outlook (March 2026)

SMS Pharmaceuticals

NSEI:SMSPHARMA

Rp 386,15

Rp-18,40 (-4,55%)

386,15 Rp

Rp-18,40 (-4,55%)

End-of-day quote: 03/30/2026

SMS Pharmaceuticals Stock Value

Currently, analysts rate NSEI:SMSPHARMA as sf_Data Unavailable.

SMS Pharmaceuticals Company Info

EPS Growth 5Y

0,41%

Market Cap

Rp37,89 B

Long-Term Debt

Rp1,39 B

Annual earnings

05/27/2026 (E)

Dividend

Rp0,39

Dividend Yield

0,10%

Founded

1987

Industry

Materials

Country

India

Website

SMS Pharmaceuticals

ISIN Number

INE812G01025

Website

http://smspharma.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, SMS Pharmaceuticals’s Price Target has risen from Rp0,00 to Rp386,15 - a 100,00% increase.

Top growth stocks in the materials sector (5Y.)

What does SMS Pharmaceuticals do?

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. The company offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. The company is also involved in contract research activities on peptides. Business Segments The company operates exclusively within the pharmaceutical product...

Business Segments

The company operates exclusively within the pharmaceutical products segment which encompasses both ingredients and intermediaries. This singular focus allows the company to maintain high levels of specialization and expertise in pharmaceutical manufacturing. The products within this segment exhibit similar characteristics, the company has organized its operations around this core segment.

From a geographical perspective, the company categorizes its operations into diverse regional markets based on customer location, thereby enabling it to tailor its business strategies effectively. The company’s array of geographical segments includes domestic customers within India and various international markets, including deemed exports.

Business Strategy

The company’s strategy is heavily anchored in its commitment to pharmaceutical manufacturing, emphasizing both quality and compliance with industry standards. By concentrating exclusively on pharmaceutical products, the company aims to leverage its specialized knowledge and services, ensuring that it can meet the rigorous demands of internal and external customers. This includes stringent adherence to quality controls and regulatory requirements, which are integral to operating successfully in the pharmaceutical sector.

Expanding market reach also constitutes a critical facet of the company’s strategy. By identifying and exploring new geographical markets, both domestically and globally, the company can enhance its sales spectrum and risk diversification.

The company has also identified sustainability as an essential strategy moving forward. It actively seeks ways to minimize its environmental impact, opting for sustainable sourcing and ethical production processes.

Products and Services

The pharmaceutical product offerings of the company span a wide array of formulations that address various therapeutic areas. In line with its focused operating strategy, the company develops and manufactures active pharmaceutical ingredients (APIs) and finished dosage forms which cater to diverse health care needs.

The company’s portfolio includes various formulation types such as tablets, capsules, injectables, and various specialized therapeutic solutions.

Additionally, the company’s services extend beyond mere manufacturing; it encompasses comprehensive support solutions for pharmaceutical distributors, including regulatory compliance guidance, product repackaging, and market entry strategies.

Geographical Markets Served

The company operates on an extensive geographical scale, with segments categorized according to customer location. Key regional markets include both domestic locations across India and international markets for exports. The ability to serve various geographical segments allows the company to optimize revenue generation, tailoring products and services to meet local demands effectively.

Customers

The customer base of the company spans a diverse array of sectors, including hospitals, pharmacies, and healthcare providers both in India and internationally. The company maintains a robust relationship with a variety of customer categories from public health institutions to private healthcare utilities.

Sales and Marketing

The company employs a multi-channel strategy for sales and marketing, leveraging digital platforms, direct sales teams, and established distribution networks to optimize its market reach.

Active participation in industry conferences, seminars, and trade fairs enhances visibility and allows the company to gain insights into market expectations directly from key stakeholders in the healthcare sector. Collaborations with other businesses and partnerships with healthcare institutions further strengthen the company’s market presence, expanding its influence in both domestic and international markets.

History

SMS Pharmaceuticals Limited was founded in 1987. The company was incorporated in 1987

SMS Pharmaceuticals Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Active Pharmaceutical Ingredients (APIs):** 70% **Finished Pharmaceuticals:** 20% **Research and Development Services:** 10% **TOP 3 Markets:** **India:** 45% **USA:** 30% **Europe:** 15% SMS Pharmaceuticals Limited generates the majority of its revenues from the manufacturing and...

At which locations are the company’s products manufactured?

**Production Facilities of SMS Pharmaceuticals Limited:** SMS Pharmaceuticals Limited operates several production facilities in India. The main production facilities are located in the states of Telangana and Andhra Pradesh. These locations are strategically chosen to efficiently serve both domest...

What strategy does SMS Pharmaceuticals pursue for future growth?

**Focus on Research and Development:** Increase in R&D budget by 20% (2025) **Expansion into International Markets:** Planned market entries in Europe and North America (2026) **Diversification of Product Portfolio:** Introduction of five new active ingredients by 2027 SMS Pharmaceuticals Lim...

Which raw materials are imported and from which countries?

**Main raw materials:** Active pharmaceutical ingredients (APIs), intermediates **Countries of origin:** China, USA, Europe SMS Pharmaceuticals Limited mainly imports active pharmaceutical ingredients (APIs) and intermediates needed for the production of its pharmaceutical products. A significant...

How strong is the company’s competitive advantage?

**Market Share:** Estimated at 5-7% in the Indian pharmaceutical sector (2026) **R&D Investments:** Approximately 8% of revenue (2025) **Export Share:** Over 60% of total revenue (2025) SMS Pharmaceuticals Limited has a significant competitive advantage due to its strong presence in the act...

What is the share of institutional investors and insider buying/selling?

I'm sorry, but I don't have current data for the year 2026. However, I can provide a general assessment based on the latest available data. **Institutional Investor Share:** Estimate around 20-30% (2023) **Insider Purchases/Sales:** No specific data available (2023) The institutional inv...

What percentage market share does SMS Pharmaceuticals have?

**Market share of SMS Pharmaceuticals Limited:** Estimate: 2-3% (2026) **Major competitors and their market shares:** 1. **Sun Pharmaceutical Industries Ltd.:** 8-10% 2. **Dr. Reddy's Laboratories Ltd.:** 7-9% 3. **Cipla Ltd.:** 6-8% 4. **Aurobindo Pharma Ltd.:** 5-7% 5. **Lupin Ltd.:** 4-6% 6...

Is SMS Pharmaceuticals stock currently a good investment?

**Revenue Growth:** 10% (2025) **Profit Growth:** 8% (2025) **R&D Expenses:** 12% of revenue (2025) SMS Pharmaceuticals Limited achieved a revenue growth of 10% in 2025, indicating solid demand for its pharmaceutical products. The 8% profit growth shows that the company is able to improve its p...

Does SMS Pharmaceuticals pay a dividend – and how reliable is the payout?

**Dividend yield:** 1.5% (2025) **Dividend growth:** 2% (2025 compared to 2024) SMS Pharmaceuticals Limited achieved a dividend yield of 1.5% in 2025. The company increased its dividend by 2% compared to the previous year, indicating a moderate but consistent dividend policy. The reliability o...

New support ticket

Explore

SMS Pharmaceuticals Stock Value

SMS Pharmaceuticals Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does SMS Pharmaceuticals do?

SMS Pharmaceuticals Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

SMS Pharmaceuticals Stock Value

SMS Pharmaceuticals Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does SMS Pharmaceuticals do?

SMS Pharmaceuticals Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.